GlassScriptPhysician profile
Julie Ann Mantis
NPI 1104349422
$1,912.59
in general payments reported to CMS, 2019-2025
14 companies · $869 in 2025
The $869 reported for 2025 was more than what 87% of Clinical Nurse Specialist providers received nationally (typical 2025 total: $150).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $66.51 · 2022: $241 · 2023: $295 · 2024: $440 · 2025: $869.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,515 · Education: $64.54 · Travel and Lodging: $24.86.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,515.40 |
| Education | $64.54 |
| Travel and Lodging | $24.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $448.15 | 2024-2025 | Minimed 780g, Intellis Adaptivestim, Inpen Smart Insulin Delivery System |
| Abbott Laboratories | $325.41 | 2024-2025 | Freestyle Libre 3, Freestyle Libre |
| Novo Nordisk INC | $205.06 | 2023-2025 | |
| Abbvie INC. | $154.72 | 2023-2025 | |
| Lilly USA, LLC | $146.77 | 2022-2024 | Trulicity, Mounjaro |
| Cequr Corporation | $143.59 | 2022-2024 | Cequr Simplicity |
| Insulet Corporation | $141.33 | 2022 | |
| Xeris Pharmaceuticals, INC. | $114.30 | 2025 | Gvoke Hypopen |
| Sanofi-Aventis U.S. LLC | $113.30 | 2021-2023 | |
| Boston Scientific Corporation | $57.96 | 2025 | Watchman Flx |
| Sequel Med Tech, LLC | $18.75 | 2025 | Twiist |
| Teva Pharmaceuticals USA, INC. | $17.07 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.96 | 2022 | |
| Dexcom, INC. | $12.22 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julie Mantis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.